By Professor Rebecca McKetin

Conference Papers

McKetin R; Shanahan M; Degenhardt L; Lee N; Baker AL; Lubman DI, 2016, 'PATTERNS OF HEALTH SERVICE UTILISATION IN A COHORT OF CHRONIC METHAMPHETAMINE USERS', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 55 - 55, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kothe A; McKetin R; Baker AL; Lee N; Ross J; Lubman DI; Mattick RP, 2016, 'PREDICTING ABSTINENCE FROM METHAMPHETAMINE USE AFTER RESIDENTIAL REHABILITATION', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 46 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500126&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mcketin R; Hickey K; Devlin C; Lawrence K, 2009, 'INTERVENTIONS FOR PSYCHOSTIMULANT USE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A76 - A76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dunlop A; Mcketin R; Salmon A; Holland R; Baker A, 2009, 'THE STIMULANT TREATMENT PROGRAM EVALUATION: CLIENT CHARACTERISTICS AND PRELIMINARY OUTCOMES', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A70 - A70, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300214&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McKetin R; Mattick RP, 1997, 'Impact of illicit amphetamine use on neuropsychological functioning', in Harris L (ed.), Problems of Drug Dependence, pp. 104 - 104, presented at Problems of Drug Dependence, 14 June 1997 - 19 June 1997

Conference Posters

Acheson L; Williams BHM; Farrell M; McKetin R; Ezard N; Siefried K, 2021, 'Pharmacological treatment for methamphetamine withdrawal: a systematic review and meta-analysis of randomised controlled trials', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Man N; Chrzanowska A; McKetin R; Price O; Gibbs D; Bruno R; Sisson S; Dietze P; Salom C; Degenhardt L; Peacock A, 2020, 'Trends in methamphetamine availability, use, and harms in Australia', presented at The 2020 NDARC Annual Research Symposium, 05 November 2020 - 26 November 2020, https://ndarc.med.unsw.edu.au/resource/trends-methamphetamine-harms-australia

Conference Presentations

Webb P; Clay S; Degenhardt L; Dawe S; McKetin R, 2024, 'Influences of methamphetamine use on family relationships: Interviews with family members', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=5s

McKetin R; Clay S, 2024, 'We need to talk about contingency management', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=7YQqzJTbdAs&t=2652s

Siefried K; McKetin R; Bedi G; Brett J; Arunogiri S; Dunlop A; Lintzeris N; Ezard N, 2021, 'Symposium: An update on pharmacotherapy trials for substance use disorder - methamphetamine type and withdrawal in Australia', presented at The APSAD Scientific Drug and Alcohol Conference, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Siefried K; Arunogiri S; Brett J; McKetin R; Acheson LS; Knock E; Farrell M; Dunlop A; Lintzeris N; Ezard N, 2021, 'The future of pharmacotherapy clinical trials in Australia: the OLAM trial; the MOXY trial; the PSIMA trial; the TINA trial', presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Conference Abstracts

Leung J; Mekonen T; Wang XX; Arunogiri S; Degenhardt L; McKetin R, 2023, 'Methamphetamine exposure and depression—A systematic review and meta-analysis', in Drug and Alcohol Review, Vol. 42, pp. 1438 - 1449, http://dx.doi.org/10.1111/dar.13670

Acheson L; Gordon C; McKetin R; Brett J; Christmass M; Rodgers C; Lintzeris N; Dunlop A; Farrell M; Shoptaw S; Ezard N; Siefried K, 2023, 'OBJECTIVE AND SUBJECTIVE SLEEP DURING LISDEXAMFETAMINE TREATMENT OF ACUTE METHAMPHETAMINE WITHDRAWAL: NEW MEASUREMENT PARADIGM', in DRUG AND ALCOHOL DEPENDENCE, ELSEVIER IRELAND LTD, CO, Denver, Vol. 260, presented at 85th Annual Scientific Meeting of the College-on-Problems-of-Drug-Dependence (CPDD), CO, Denver, 17 July 2023 - 21 July 2023, http://dx.doi.org/10.1016/j.drugalcdep.2023.110067

Williams BH; Acheson LS; Farrell M; McKetin R; Ezard N; Siefried KJ; Farrell M, 2022, 'PHARMACOLOGICAL TREATMENT FOR METHAMPHETAMINE WITHDRAWAL: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 56, pp. 208 - 209

Reilly R; McKetin R; Butt J; Smout M; Clark Y; Roe Y; Ezard N; Dunlop AJ; Conigrave KM; Quinn B; Treloar C; Gray D; Wilkes E; Fisher I; Longbottom W; Ward J, 2019, 'A NOVEL WEB-APP TO ASSIST ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE TO REDUCE OR STOP USING METHAMPHETAMINE: WE CAN DO THIS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S86 - S86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100216&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McKetin R; Leung J; Stockings E; Huo P; Foulds J; Lappin J; Cumming C; Arunogiri S; Young J; Sara G; Farrell M; Degenhardt L, 2019, 'MENTAL HEALTH CONSEQUENCES OF METHAMPHETAMINE USE: A SYSTEMATIC REVIEW AND META-ANALYSIS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S72 - S72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100181&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reilly R; Wand H; McKetin R; Ezard N; Dunlop AJ; Conigrave KM; Quinn B; Gray D; Wilkes E; Treloar C; Fisher I; Longbottom W; Ward J, 2019, 'METHODS OF DATA COLLECTION AND CHARACTERISTICS OF A SAMPLE OF METHAMPHETAMINE USERS: FINDINGS FROM THE NOVEL INTERVENTIONS TO ADDRESS METHAMPHETAMINE USE IN ABORIGINAL AND TORRES STRAIT ISLANDER COMMUNITIES SURVEY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S86 - S87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Quinn B; Ward B; Hall C; Jenkinson R; Cossar R; Agius P; Sutton K; Hickman M; McKetin R; Farrell M; Dietze P, 2019, 'SYMPOSIUM: INVESTIGATING METHAMPHETAMINE USE AND RELATED HARMS IN METROPOLITAN, REGIONAL AND RURAL VICTORIA VIA THE ONGOING PROSPECTIVE COHORT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S19 - S20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Whetton S; Tait RJ; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Allsop S, 2018, 'HARMS TO RESIDENT ADULTS AND ADULT FAMILY MEMBERS OF A PERSON DEPENDENT ON METHAMPHETAMINE: COUNTING THE COSTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S74 - S75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000183&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tait RJ; Allsop S; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Whetton S; Shanahan M, 2018, 'REMEDIATION AND PROPERTY VALUES: THE COSTS OF CLANDESTINE METHAMPHETAMINE MANUFACTURING IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S69 - S70, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000173&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McKetin R; Gardner J; Baker AL; Dawe S; Ali R; Voce A; Leach L; Lubman DI, 2016, 'CORRELATES OF TRANSIENT VERSUS PERSISTENT PSYCHOTIC SYMPTOMS AMONG DEPENDENT METHAMPHETAMINE USERS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 54 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ezard N; Dunlop AJ; Carr A; McKetin R; Ali R; White J; Bruno R; Dolan K; Clifford B; Lintzeris N, 2016, 'A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE: THE LIMA STUDY PROTOCOL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 35 - 36

Reports

McKetin R; Thapa P; Uthurralt N; Bo A; Degenhardt L; Farrell M; Mounteney J; Griffiths P; Degan T, 2023, An Overview Of The Evidence For Substance Use Interventions, NDARC, Sydney, http://dx.doi.org/10.26190/yb4b-1c31, https://ndarc.med.unsw.edu.au/resource/overview-evidence-substance-use-interventions

Man N; Sisson S; McKetin R; Chrzanowska A; Bruno R; Dietze P; Price O; Degenhardt L; Gibbs D; Salom C; Peacock A, 2022, Trends in methamphetamine use, markets and harms in Australia, 2003-2019, NDARC, Sydney, http://dx.doi.org/10.26190/ad59-k695

Karlsson A; Peacock A; McKetin R; Ezard N; Sutherland R, 2022, Crystal methamphetamine and use of commercial pipes amongst a sentinel sample of people who regularly use ecstasy and other illicit stimulants in Australia, 2021, NDARC, Sydney, http://dx.doi.org/10.26190/1th5-0a05

Vogl LE; Newton NC; Teesson M; Swift W; Karageorge A; Deans C; McKetin R; Steadman B; Jones J; Dillon P; Havard AE; Andrews G, 2012, Climate Schools: Universal computer-based programs to prevent alcohol and other drug use in adolescence, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, 321, http://ndarc.med.unsw.edu.au/resource/climate-schools-universal-computer-based-programs-prevent-alcohol-and-other-drug-use

Vogl LE; Newton NC; Teesson M; Swift W; Karageorge A; Havard A; Deans C; McKetin R; Steadman B; Dillon P; Andrews G, 2009, Climate Schools: Drug prevention programs, Prepared for Australian Government Department of Health and Ageing, Sydney

Torok M; Darke S; Kaye SS; Ross JE; McKetin R, 2008, Comparative rates of violent crime amongst methamphetamine and opioid users : victimistation and offending, National Drug Law Enforcement Research Fund (NDLERF), Hobart, Monograph Series No. 32, http://www.ndlerf.gov.au/pub/Monograph_32.pdf

Wardlaw G; Hetherington K; McKetin R, 2008, Final Report: Illicit Drug Reporting System. Consultant`s report to the Commonwealth Department of Human Services and Health, National Drug and Alcohol Research Centre, Sydney

Hetherington K; McKetin R, 2008, The contribution of cannabis use to psychotic symptoms among methamphetamine treatment entrants, National Drug and Alcohol Research Centre, Sydney, https://ndarc.med.unsw.edu.au/resource/contribution-cannabis-use-psychotic-symptoms-among-methamphetamine-treatment-entrants

Theses / Dissertations

McKetin R, 1999, Cognitive functioning and psychological morbidity among illicit amphetamine users

Preprints

Sivak L; Reilly R; Crumpen S; Treloar C; McKetin R; Butt J; Roe Y; Ezard N; Quinn B; Nagle J; Longbottom W; Warrior C; Ward J, 2024, An acceptability and feasibility study of the We Can Do This web-app in Australian primary care and residential rehabilitation settings for Aboriginal and Torres Strait Islander people who use methamphetamine (Preprint), http://dx.doi.org/10.2196/preprints.58369

Reilly R; McKetin R; Barzi F; Degan T; Ezard N; Conigrave K; Butt J; Roe Y; Wand H; Quinn B; Longbottom W; Treloar C; Dunlop A; Ward J, 2024, Web-Based Application for Reducing Methamphetamine Use Among Aboriginal and Torres Strait Islander People: Randomized Waitlist Controlled Trial (Preprint), http://dx.doi.org/10.2196/preprints.58341

McKetin R; Degan T; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly P; Turner A; Clare P; Dean O; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BT-F; Kegan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland R; Byrne M; Zahra E; Russell S; Berk M, 2024, A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: A study protocol for the Tina Trial, http://dx.doi.org/10.21203/rs.3.rs-3984655/v1

Reilly R; McKetin R; Wand H; Butt J; Smout M; Ezard N; Conigrave K; Quinn B; Treloar C; Gray D; Dunlop A; Wilkes E; Ward J, 2019, ‘We Can Do This’: a web-based therapeutic program for reducing methamphetamine use and increasing help-seeking amongst Aboriginal and Torres Strait Islander people: Wait-list control, randomised trial protocol (Preprint), http://dx.doi.org/10.2196/preprints.14084

Hides L; Chan G; Dawe S; McKetin R; Kavanagh DJ; Young R; Teesson M; Saunders JB, Bidirectional Relationship Between Methamphetamine Use and Positive Psychotic Symptoms in Regular Methamphetamine Users: Evidence From a Prospective Cohort Study, http://dx.doi.org/10.2139/ssrn.3260803

Back to profile page